Kaleido Biosciences Company Profile

05:23 EST 12th December 2018 | BioPortfolio

Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maintain health. Since its founding in 2015 by Flagship VentureLabs, Kaleido has advanced candidate products into clinical studies across programs in rare genetic diseases, oncology and infectious disease, and has generated more than 3,000 days of human clinical data. The Company is also creating consumer products that optimize the microbiome's natural roles in promoting health.

News Articles [600 Associated News Articles listed on BioPortfolio]

Kaleido Biosciences raises $101m to advance pipeline

Clinical-stage healthcare company firm Kaleido Biosciences has raised $101m in an oversubscribed series C financing.

Kaleido Bio Promotes Alison Lawton to CEO, Joshua Brumm to COO

Alison Lawton, president and chief operating officer of Kaleido Biosciences, has been appointed CEO of the microbiome therapies developer. Lawton succeeds Michael Bonney, who will now serve as executi...

Kaleido Biosciences closes $101mm Series C round

Kaleido Biosciences (optimizing the human microbiome to treat disease) raised $101mm through its Series C round. Founding investor Flagship Pioneering participated, along with a subsidiary of the Abu ...

GSK’s Katharine Knobil Joins Kaleido Bio as Chief Medical Officer

Katharine Knobil has been appointed chief medical officer and head of research and development of Kaleido Biosciences. Knobil joins Lexington, MA-based Kaleido from GlaxoSmithKline (NYSE: GSK) where s...

Kaleido raises $101 million to target microbiome

Massachusetts-based Kaleido Biosciences has brought in $101 million in Series C funding to advance its microbiome-targeting therapeutic pipeline.

Kaleido ends oversubscribed funding round at $101m

Microbiome startup Kaleido Biosciences has closed its oversubscribed Series C financing round at $101m. Investment came from Fidelity Management, Invus,...Read More... The post Kaleido ends oversubscr...

#news #biotech Kaleido brings in $101M in series C for its microbiome-wide therapy pipeline

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Kaleido brings in $101M in series C for its microbiome-wide therapy pipeline ...

Venture Funding Deals: I-Mab Is The Mega-Round Leader With $220m Series C

Freeline Therapeutics, I-Mab Biopharma, Kaleido Biosciences and Precision BioSciences raised more than $100m each, but Chinese start-ups continue to bring...   

Drugs and Medications [13 Associated Drugs and Medications listed on BioPortfolio]

Naturally nova scotia hand sanitizer [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Anhydrous spf 30 [Owen Biosciences, Inc.]

Drug Facts

Natelle one [Azur Pharma, Inc.]

Natelle OneRx Prenatal Vitamin & Plant-Based DHA Now with 28 mg Iron

Natelle one [Azur Pharma, Inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [8 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Validation of Decipher Test in African American Men With Prostate Cancer - VANDAAM

The primary purpose of this study is to determine whether a tumor test recently developed by GenomeDx Biosciences known as Decipher® can predict aggressive prostate cancer with the same a...

Companies [372 Associated Companies listed on BioPortfolio]

Kaleido Biosciences

Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The ...

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

More Information about "Kaleido Biosciences" on BioPortfolio

We have published hundreds of Kaleido Biosciences news stories on BioPortfolio along with dozens of Kaleido Biosciences Clinical Trials and PubMed Articles about Kaleido Biosciences for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kaleido Biosciences Companies in our database. You can also find out about relevant Kaleido Biosciences Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record